SOPs for BA-BE Studies V 2.0

To define the procedure for training all relevant clinical staff on protocol amendments to ensure proper implementation and regulatory compliance in BA/BE studies.
Click to read the full article.

To establish a contingency plan for managing power outages or equipment malfunctions during the clinical phase of BA/BE studies, thereby ensuring subject safety, sample integrity, and uninterrupted data collection.
Click to read the full article.

To define the standard protocol for safe evacuation and conduct of fire drills at the clinical site conducting Bioavailability/Bioequivalence (BA/BE) studies, ensuring preparedness for emergencies and minimizing risks to volunteers and staff.
Click to read the full article.

To establish a standardized procedure for maintaining the privacy and confidentiality of volunteer identity and data during all phases of Bioavailability/Bioequivalence (BA/BE) studies in compliance with ICH GCP, Schedule Y, and national ethical standards.
Click to read the full article.

To define the procedure for proper identification, unique ID assignment, and documentation of volunteer screening and eligibility logs in Bioavailability/Bioequivalence (BA/BE) studies, ensuring compliance with regulatory and ethical standards.
Click to read the full article.

To establish a standardized procedure for the ethical inclusion and management of female volunteers in Bioavailability/Bioequivalence (BA/BE) studies, ensuring subject safety, regulatory compliance, and gender-sensitive practices.
Click to read the full article.

To establish a systematic procedure for managing subject dropouts and implementing replacements in Bioavailability/Bioequivalence (BA/BE) studies, ensuring protocol compliance, data integrity, and subject safety.
Click to read the full article.

To define the procedure for the lawful and safe use of controlled substances in Bioequivalence (BE) studies including their procurement, receipt, storage, dispensing, administration, accountability, and destruction, in accordance with NDPS Act and regulatory requirements.
Click to read the full article.

To establish a controlled and ethical procedure for capturing and managing photographic and video documentation during Bioequivalence (BE) studies in accordance with regulatory and ethical standards.
Click to read the full article.

To establish a systematic procedure for reconciling the clinical samples collected during Bioavailability/Bioequivalence (BA/BE) studies to ensure sample traceability, prevent loss or misidentification, and maintain integrity of the study.
Click to read the full article.